Veraxa Biotech (Group)

https://www.veraxa.de

VERAXA Biotech is a fusion of Velabs Therapeutics GmbH and Araxa Biosciences GmbH, both spin-off companies of Europe's most renowned institute for life science research and instrument development, the European Molecular Biology Laboratory (EMBL), which is at the forefront of microfluidics-based screening technology and applications worldwide. The Company's droplet-based microfluidic screening technology and its innovative antibody and protein conjugation technology allows for a rapid generation of antibodies against most complex target molecules and for a target product profile sharpening of existing mAb candidates in oncology or precision medicine. VERAXA is a preferred license & cooperation partner of global biotech and pharma industries. *

	Start	2021-05-21 merged
	Predecessor	Velabs Therapeutics GmbH
	Industry	microfluidics technology
	Industry 2	drug discovery services
	Person	Antz, Cristoph (Veraxa Biotech 202106 Managing Director before Acousia Therapeutics + Elara + EMBL Ventures + Abeta)

	Region	Heidelberg
	Country	Germany
	Street	1 Meyerhofstr.
	City	69117 Heidelberg
		Address record changed: 2021-06-14

Basic data	Employees	n. a.

		* Document for »About Section«: Veraxa Biotech GmbH. (6/14/21). "Press Release: Veraxa Biotech and Quadira Biosciences Enter Partnership on ADC Development". Heidelberg.

		Record changed: 2024-12-29